{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T10:57:07Z","timestamp":1785581827044,"version":"3.56.0"},"reference-count":25,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T00:00:00Z","timestamp":1722124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Despite continuous improvements in revascularization techniques, refractory angina without potential revascularization options remains a relevant clinical issue with significant impact on the patient\u2019s quality of life. Recently, a novel device, the Coronary Sinus Reducer (CSR), has been introduced into clinical practice as a therapeutic option for patients with disabling angina pectoris. In this single-center, observational study, we evaluated the mid-term (3-month) safety and efficacy of the CSR in a real-world cohort. Methods: The study population consisted of 55 patients with refractory angina without potential revascularization options, who were predominantly men (87.3%) with a high cardiovascular risk factor burden and advanced angina (baseline CCS angina class 3.15 \u00b1 0.6). In terms of procedure safety, all patients underwent successful device deployment with only one periprocedural complication. Results: At the 3-month follow-up, we observed a statistically significant improvement in angina control measured CCS class and SAQ-7 total questionnaire along with increased abolition of physical limitation\u20146-MWT (233.3 \u00b1 107.1 vs. 305.2 \u00b1 126.8; p &lt; 0.0001). Additionally, we observed significant improvement in terms of quality of life measurements SF-36, the EQ-5D-5L questionnaire, and the EQ-VAS. Conclusions: Our real-world data suggest that CSR implantation is a relatively safe procedure and appears to be particularly effective in relieving angina symptoms and improving quality of life in subjects with refractory angina.<\/jats:p>","DOI":"10.3390\/jcm13154413","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T09:50:05Z","timestamp":1722246605000},"page":"4413","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Safety and Effectiveness of Coronary Sinus Reducer in the Therapy of Refractory Angina Pectoris\u2014Mid-Term Results of the Real-Life Cohort"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9886-0310","authenticated-orcid":false,"given":"Szymon","family":"W\u0142odarczak","sequence":"first","affiliation":[{"name":"Department of Cardiology, Copper Health Centre (MCZ), 59-300 Lubin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0963-2712","authenticated-orcid":false,"given":"Piotr","family":"Rola","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Provincial Specialized Hospital, 59-200 Legnica, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur","family":"Jastrz\u0119bski","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Copper Health Centre (MCZ), 59-300 Lubin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol","family":"Turkiewicz","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Copper Health Centre (MCZ), 59-300 Lubin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Korda","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Copper Health Centre (MCZ), 59-300 Lubin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"W\u0142odarczak","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Copper Health Centre (MCZ), 59-300 Lubin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9112-8012","authenticated-orcid":false,"given":"Mateusz","family":"Barycki","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Provincial Specialized Hospital, 59-200 Legnica, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6670-6044","authenticated-orcid":false,"given":"Jan Jakub","family":"Kulczycki","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Copper Health Centre (MCZ), 59-300 Lubin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Furtan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Provincial Specialized Hospital, 59-200 Legnica, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3104-7728","authenticated-orcid":false,"given":"Adrian","family":"W\u0142odarczak","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Copper Health Centre (MCZ), 59-300 Lubin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Lesiak","sequence":"additional","affiliation":[{"name":"1st Department of Cardiology, University of Medical Sciences, 61-701 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e009002","DOI":"10.1161\/CIRCINTERVENTIONS.120.009002","article-title":"Therapeutic Approaches for the No-Option Refractory Angina Patient","volume":"14","author":"Povsic","year":"2021","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/ccd.27707","article-title":"Revascularization in \u201cno option\u201d patients with refractory angina: Frequency, etiology and outcomes","volume":"92","author":"Sharma","year":"2018","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.jcin.2015.06.017","article-title":"Prevalence of coronary microvascular dysfunction among patients with chest pain and nonobstructive coronary artery disease","volume":"8","author":"Sara","year":"2015","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcin.2019.08.055","article-title":"Refractory Angina: From Pathophysiology to New Therapeutic Nonpharmacological Technologies","volume":"13","author":"Gallone","year":"2020","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.jacc.2007.01.061","article-title":"Coronary sinus reducer stent for the treatment of chronic refractory angina pectoris: A prospective, open-label, multicenter, safety feasibility first-in-man study","volume":"49","author":"Banai","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/eurheartj\/ehx486","article-title":"The Reducer device in patients with angina pectoris: Mechanisms, indications, and perspectives","volume":"39","author":"Konigstein","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12968-018-0462-y","article-title":"Fully automated, inline quantification of myocardial blood flow with cardiovascular magnetic resonance: Repeatability of measurements in healthy subjects","volume":"20","author":"Brown","year":"2018","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s11886-022-01820-3","article-title":"Persistent or Recurrent Angina Following Percutaneous Coronary Revascularization","volume":"24","author":"Ajmal","year":"2022","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Fezzi, S., Ding, D., Mahfoud, F., Huang, J., Lansky, A.J., Tu, S., and Wijns, W. (Nat. Rev. Cardiol., 2024). Illusion of revascularization: Does anyone achieve optimal revascularization during percutaneous coronary intervention?, Nat. Rev. Cardiol., online ahead of print.","DOI":"10.1038\/s41569-024-01014-0"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jcin.2018.01.251","article-title":"Coronary Sinus Reducer Implantation for the Treatment of Chronic Refractory Angina: A Single-Center Experience","volume":"11","author":"Giannini","year":"2018","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"561","DOI":"10.4244\/EIJ-D-20-00873","article-title":"Coronary sinus narrowing for the treatment of refractory angina: A multicentre prospective open-label clinical study (the REDUCER-I study)","volume":"17","author":"Verheye","year":"2021","journal-title":"EuroIntervention"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"508","DOI":"10.33963\/KP.a2023.0057","article-title":"Coronary Sinus Reducer implantation in refractory angina: Short-term outcomes based on the Lower Silesia Sinus Reducer Registry (LSSRR)","volume":"81","author":"Rola","year":"2023","journal-title":"Kardiol. Pol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s12471-020-01525-8","article-title":"The Coronary Sinus Reducer; 5-year Dutch experience","volume":"29","author":"Silvis","year":"2021","journal-title":"Neth. Heart J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/clc.23566","article-title":"Long-term outcomes of patients undergoing coronary sinus reducer implantation\u2014A multicenter study","volume":"44","author":"Konigstein","year":"2021","journal-title":"Clin. Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijcard.2019.05.026","article-title":"Safety and efficacy of Coronary Sinus Reducer implantation at 2-year follow-up","volume":"292","author":"Ponticelli","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.repc.2022.05.010","article-title":"Coronary sinus Reducer device for the treatment of refractory angina: A multicenter initial experience","volume":"42","author":"Madeira","year":"2023","journal-title":"Rev. Port. Cardiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2217\/fca-2021-0064","article-title":"Coronary sinus reducer for the treatment of chronic refractory angina pectoris","volume":"18","author":"Ponticelli","year":"2022","journal-title":"Future Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cjca.2021.12.009","article-title":"Effectiveness of Coronary Sinus Reducer for Treatment of Refractory Angina: A Meta-analysis","volume":"38","author":"Hochstadt","year":"2022","journal-title":"Can. J. Cardiol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Mrak, M., Pav\u0161i\u010d, N., \u017di\u017eek, D., Le\u017eai\u0107, L., and Bunc, M. (2023). Effect of Coronary Sinus Reducer Implantation on Aerobic Exercise Capacity in Refractory Angina Patients\u2014A CROSSROAD Study. J. Cardiovasc. Dev. Dis., 10.","DOI":"10.3390\/jcdd10060235"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijcard.2018.06.116","article-title":"Safety and efficacy of the reducer: A multi-center clinical registry\u2014REDUCE study","volume":"269","author":"Giannini","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(24)00256-3","article-title":"Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): A randomised, placebo-controlled trial","volume":"403","author":"Foley","year":"2024","journal-title":"Lancet"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e009148","DOI":"10.1161\/CIRCIMAGING.119.009148","article-title":"Patterns of Regional Myocardial Perfusion Following Coronary Sinus Reducer Implantation: Insights by Stress Cardiac Magnetic Resonance","volume":"12","author":"Giannini","year":"2019","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1378\/chest.13-2885","article-title":"OSA and depression are common and independently associated with refractory angina in patients with coronary artery disease","volume":"146","author":"Geovanini","year":"2014","journal-title":"Chest"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1136\/hrt.2009.176040","article-title":"Psychotropic medication use and risk of adverse cardiovascular events in women with suspected coronary artery disease: Outcomes from the Women\u2019s Ischemia Syndrome Evaluation (WISE) study","volume":"95","author":"Krantz","year":"2009","journal-title":"Heartn"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/15\/4413\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:25:21Z","timestamp":1760109921000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/15\/4413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,28]]},"references-count":25,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["jcm13154413"],"URL":"https:\/\/doi.org\/10.3390\/jcm13154413","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,28]]}}}